3rd Annual Microbiome Drug Development Summit
Boston Analytical will be exhibiting.
A dedicated forum in tackling the challenges of developing a microbiome-based therapeutic, Microbiome Drug Development Summit will use industry case studies to develop your knowledge around four core areas of therapeutic advancement :
- Scientific Activities- Translating microbiome data into a succesful health-care product
- Clinical Activities- Obtaining decisive human data in a safe and timely manner
- Regulatory Activities- Outlining clear regulatory paths that guarantee success
- Financial Activities- Maximising shareholder value and sustaining growth
Part of the global “Microbiome Movement Series” the Microbiome Drug Development Summit will be the foremost event for industry leaders to help accelerate the precise translation of microbiome R&D from disease causation into safe, effective and commercially scalable therapeutics.